
Investors Urged to Join GRAIL Securities Fraud Class Action
Investors who purchased GRAIL, Inc. stock between May 13, 2025, and February 19, 2026, face an August 4, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation alleges the company misled stakeholders regarding the clinical prospects of its NHS-Galleri cancer trial.






















